Skip to main content

RAB3 GTPase activating non-catalytic protein subunit 2

The RAB3GAP2 gene provides instructions for making a protein that helps regulate the activity of specialized proteins called GTPases, which control a variety of functions in cells. To perform its function, the RAB3GAP2 protein interacts with another protein called RAB3GAP1 (produced from the RAB3GAP1 gene) to form the RAB3GAP complex.

Normal function

The RAB3GAP2 gene provides instructions for making a protein that helps regulate the activity of specialized proteins called GTPases, which control a variety of functions in cells. To perform its function, the RAB3GAP2 protein interacts with another protein called RAB3GAP1 (produced from the RAB3GAP1 gene) to form the RAB3GAP complex.

Often referred to as molecular switches, GTPases can be turned on and off. They are turned on (active) when they are attached (bound) to a molecule called GTP and are turned off (inactive) when they are bound to another molecule called GDP. The RAB3GAP complex turns on a GTPase known as RAB18 by exchanging GTP for the attached GDP. When active, RAB18 is involved in a process called vesicle trafficking, which moves proteins and other molecules within cells in sac-like structures called vesicles. RAB18 regulates the movement of substances between compartments in cells and the storage and release of fats (lipids) by structures called lipid droplets. The protein also appears to play a role in a process called autophagy, which helps clear unneeded materials from cells. RAB18 is important for the organisation of a cell structure called the endoplasmic reticulum, which is involved in protein processing and transport.

The RAB3GAP complex is also thought to inactivate another GTPase known as RAB3 by stimulating a reaction that turns the attached GTP into GDP. RAB3 plays a role in the release of hormones and brain chemicals (neurotransmitters) from cells.

Conditions referring to this gene or chromosome

Other names

DKFZP434D245

KIAA0839

p150

RAB3 GTPase activating protein subunit 2 (non-catalytic)

rab3 GTPase-activating protein 150 kDa subunit

rab3 GTPase-activating protein non-catalytic subunit

rab3-GAP p150

rab3-GAP regulatory subunit

RAB3-GAP150

RAB3GAP150

RGAP-iso

SPG69

WARBM2

Related patient information and medicines

Can I take Mirabegron and Rivaroxaban together?

Patient information leaflet

Can I take Mirabegron and Rivaroxaban together?

Taking these two medicines together... Why this happens Mirabegron and rivaroxaban are processed by different pathways in the body. Mirabegron is primarily broken down by enzymes called CYP3A4 and CYP2D6, while rivaroxaban is processed by CYP3A4 and a transport protein called P-gp. While they share the CYP3A4 pathway, studies show that mirabegron.

Healthy eating

Patient information leaflet

Healthy eating

You can reduce your intake of trans fats by ... A 2019 review by the SACN (The Scientific Advisory Committee on Nutrition) determined that reducing your intake of saturated fats lowers your risk of developing coronary heart disease, although there was no evidence that it reduces the rate of dying from these conditions. We do not yet know the long.

The immune system

Patient information leaflet

The immune system

This leaflet gives a brief overview of the immune system and how it works. A person with a weak immune system might have difficulty fighting off infections. In autoimmune diseases the body is unable to tell what is its own and what is foreign, so it attacks itself. Autoimmune diseases can attack any part of the body - eg, type 1 diabetes.

Paleolithic diet (paleo diet)

Patient information leaflet

Paleolithic diet (paleo diet)

Following a Paleolithic diet means eating unprocessed, fresh foods that reflect the diet of our hunter-gatherer ancestors from the Paleolithic era. It involves avoiding any foods that were not available to these 'cavemen' at that time, including processed foods, grains and dairy products. The staple foods of a Paleolithic diet include meat and.

Granulomatosis with polyangiitis

Patient information leaflet

Granulomatosis with polyangiitis

Treatment with medicines to reduce the activity of the immune system and treatment with steroids have improved the outlook considerably. What is granulomatosis with polyangiitis and who develops it. Granulomatosis with polyangiitis (GPA) is one of a group of conditions that causes inflammation of the blood vessels of the body (vasculitis). GPA.

Anticoagulants

Patient information leaflet

Anticoagulants

How do anticoagulants work. Our blood has a complex system of chemicals in it, which, when activated, cause blood clots to form. This is called the clotting cascade. This is normally a good thing; it's activated if we have an injury, like a bleeding wound. The clotting cascade causes a clot to form, stopping the bleeding. However, some people get.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 Apr 2018 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
flu eligibility checker

Ask, share, connect.

Browse discussions, ask questions, and share experiences across hundreds of health topics.

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.